[1] 胡增涛,王微娜,孙东升,等.食管鳞状细胞癌中环状RNA的生物学功能与调控机制研究[J].临床误诊误治,2020,295(3):127-130.
[2] 李孝鹏,丁宁,白光平,等.新辅助放化疗联合手术与单纯手术治疗局部晚期食管癌的疗效比较[J].肿瘤防治研究,2014,41(5):464-467.
[3] KONG X,DUAN Y,SANG Y,et al.LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215[J].J Cell Physiol,2019,234(6):9105-9117.
[4] BHAN A,SOLEIMANI M,MANDAL S S.Long noncoding RNA and cancer:a new paradigm[J].Cancer Res,2017,77(15):3965-3981.
[5] KONG X,DUAN Y,SANG Y,et al.LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215[J].J Cell Physiol,2019,234(6):9105-9117.
[6] CAO H L,LIU Z J,HUANG P L,et al.lncRNA-RMRP promotes proliferation,migration and invasion of bladder cancer via miR-206[J].Eur Rev Med Pharmacol Sci,2019,23(3):1012-1021.
[7] ZHANG C,LIAN H,XIE L,et al.LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p[J].Biol Chem,2020,401(9):1053-1061.
[8] ZHAO W,HUANG Z,LIU H,et al.LncRNA GIHCG promotes the development of esophageal cancer by modulating miR-29b-3p/ANO1 axis[J].Onco Targets Ther,2020,31(13):13387-13400.
[9] ZHANG J J,XU W R,CHEN B,et al.The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation,invasion and migration via modulating PI3K/AKT/mTOR pathway[J].Eur Rev Med Pharmacol Sci,2019,23(19):8321-8331.
[10] HU Y,SUN H,HU J,et al.LncRNA DLX6-AS1 promotes the progression of neuroblastoma by activating STAT2 via targeting miR-506-3p[J].Cancer Manag Res,2020,19(12):7451-7463.
[11] 罗莉,刘玉荣,苏磊.食管鳞癌患者血清TK1与SCCA表达及其预后价值[J].中华肿瘤防治杂志,2020,27(5):29-35.
[12] TAN Y T,LIN J F,LI T,et al.LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J].Cancer Commun (Lond),2021,41(2):109-120.
[13] NIE K,DENG Z,ZHENG Z,et al.Identification of a 14-lncRNA signature and construction of a prognostic nomogram predicting overall survival of gastric cancer[J].DNA Cell Biol,2020,39(9):1532-1544.
[14] WANG K,YAN L,LU F.miR-144 inhibits osteosarcoma cell proliferation and invasion via targeting SOX4[J].Oncology Research,2018,27(2):157-163.
[15] WU Q,MA J,MENG W,et al.DLX6-AS1 promotes cell proliferation,migration and EMT of gastric cancer through FUS-regulated MAP4K1[J].Cancer Biol Ther,2020,21(1):17-25.
[16] WANG H,NIU X,JIANG H,et al.Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway[J].Aging (Albany NY),2020 Aug 3;12(16):16021-16034.
[17] CHENG B,ZHANG Y,WU Z W,et al.MiR-144 inhibits colorectal cancer cell migration and invasion by regulating PBX3[J].Eur Rev Med Pharmacol Sci,2020,24(18):9361-9369.
[18] HAN S,ZHU J,ZHANG Y.miR-144 potentially suppresses proliferation and migration of ovarian cancer cells by targeting RUNX1[J].Med Sci Monit Basic Res,2018,15(24):40-46.
[19] YUMIMOTO K,NAKAYAMA K I.Recent insight into the role of FBXW7 as a tumor suppressor[J].Semin Cancer Biol,2020,67(Pt 2):1-15.
[20] KUAI X,LI L,CHEN R,et al.SCFFBXW7/GSK3β-Mediated GFI1 degradation suppresses proliferation of gastric cancer cells[J].Cancer Res,2019,79(17):4387-4398. |